modelJ02AX04

Diagram of J02AX04

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Caspofungin
ATC code:J02AX04
route:intravenous
compartments:2
dosage:70mg
volume of distribution:9.7L
clearance:0.55l/h
other parameters in model implementation

Caspofungin is an echinocandin antifungal agent approved for the treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies, as well as for empirical therapy for presumed fungal infections in febrile neutropenic patients. It is also used against Candida infections, including candidemia and esophageal candidiasis.

Pharmacokinetics

Pharmacokinetic parameters reported for adult healthy volunteers and patients with invasive fungal infections. Intravenous infusion. Parameters represent typical administration of a 70 mg loading dose followed by 50 mg daily.

References

  1. Borsuk-De Moor, A, et al., & Wiczling, P (2020). Nonstationary Pharmacokinetics of Caspofungin in ICU Patients. Antimicrobial agents and chemotherapy 64(9) –. DOI:10.1128/AAC.00345-20 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32601169

  2. Li, CC, et al., & Stone, JA (2011). Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patients. Antimicrobial agents and chemotherapy 55(5) 2098–2105. DOI:10.1128/AAC.00905-10 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21300834

  3. Leshinsky, J, et al., & Barrs, VR (2017). Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats. PloS one 12(6) e0178783–None. DOI:10.1371/journal.pone.0178783 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28575121

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)